Artificial intelligence in pathologic diagnosis, prognosis and prediction of prostate cancer
American Journal of Clinical and Experimental Urology · 2024 · 12 (4) · 200-215
DOI: 10.62347/jsae9732 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Clinical and Experimental Urology, 2024. Verfasst von Min Zhu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Computational Pathology, NovinoAI 1443 NE 4th Ave, Fort Lauderdale, FL 33304, USA. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Histopathology, which is the gold-standard for prostate cancer diagnosis, faces significant challenges. With prostate cancer ranking among the most common cancers in the United States and worldwide, pathologists experience an increased number for prostate biopsies. At the same time, precise pathological assessment and classification are necessary for risk stratification and treatment decisions in prostate cancer care, adding to the challenge to pathologists. Recent advancement in digital pathology makes artificial intelligence and learning tools adopted in histopathology feasible. In this review, we introduce the concept of AI and its various techniques in the field of histopathology. We summarize the clinical applications of AI pathology for prostate cancer, including pathological diagnosis, grading, prognosis evaluation, and treatment options. We also discuss how AI applications can be integrated into the routine pathology workflow. With these rapid advancements, it is evident that AI applications in prostate cancer go beyond the initial goal of being tools for diagnosis and grading. Instead, pathologists can provide additional information to improve long-term patient outcomes by assessing detailed histopathologic features at pixel level using digital pathology and AI. Our review not only provides a comprehensive summary of the existing research but also offers insights for future advancements.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Computational Pathology, NovinoAI 1443 NE 4th Ave, Fort Lauderdale, FL 33304, USA.
- Department of Radiation Oncology, Stanford University School of Medicine Stanford, CA 94305, USA.
- King Hussein School of Computing Sciences, Princess Sumaya University for Technology Amman 11855, Jordan.
- College of Agriculture and Life Sciences, Cornell University 616 Thurston Ave, Ithaca, NY 14853, USA.
- Department of Surgery, Florida Atlantic University, Division of Urology, Bethesda Hospital East, Baptist Health South Florida 2800 S. Seacrest Drive, Boynton Beach, FL 33435, USA.
- Department of Radiation Medicine, New York Medical College and Westchester Medical Center Valhalla, NY 10595, USA.
Zitieren
APA
Zhu, M., Sali, R., Baba, F., Khasawneh, H., Ryndin, M., Leveillee, R. J., Hurwitz, M. D., Lui, K., Dixon, C., & Zhang, D. Y. (2024). Artificial intelligence in pathologic diagnosis, prognosis and prediction of prostate cancer. American Journal of Clinical and Experimental Urology, 12(4), 200-215. https://doi.org/10.62347/jsae9732
Vancouver
Zhu M, Sali R, Baba F, Khasawneh H, Ryndin M, Leveillee RJ, et al. Artificial intelligence in pathologic diagnosis, prognosis and prediction of prostate cancer. American Journal of Clinical and Experimental Urology. 2024;12(4):200-215. doi:10.62347/jsae9732
BibTeX
@article{Zhu2024,
author = {Zhu, Min and Sali, Rasoul and Baba, Firas and Khasawneh, Hamdi and Ryndin, Michelle and Leveillee, Raymond J and Hurwitz, Mark D and Lui, Kin and Dixon, Christopher and Zhang, David Y},
title = {Artificial intelligence in pathologic diagnosis, prognosis and prediction of prostate cancer},
journal = {American Journal of Clinical and Experimental Urology},
year = {2024},
volume = {12},
number = {4},
pages = {200--215},
doi = {10.62347/jsae9732}
}
EUVIMED